1
|
Guertler A, Neu K, Lill D, Clanner-Engelshofen B, French LE, Reinholz M. Exploring the potential of omega-3 fatty acids in acne patients: A prospective intervention study. J Cosmet Dermatol 2024. [PMID: 38982829 DOI: 10.1111/jocd.16434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2024] [Revised: 05/31/2024] [Accepted: 06/11/2024] [Indexed: 07/11/2024]
Abstract
BACKGROUND Omega-3 fatty acids (ω-3 FA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), are essential nutrients known for their anti-inflammatory properties, which involve reducing pro-inflammatory cytokines, eicosanoids, and insulin-like growth factor-1. This suggests their potential to alleviate acne severity, especially when deficits are present. AIMS To elevate EPA/DHA levels in acne patients through dietary intervention and supplementation, observing subsequent clinical effects. METHODS Over 16 weeks, 60 patients without prescription medication (n = 23 acne comedonica [AC], n = 37 acne papulopustulosa [AP]) adhered to a Mediterranean diet, incorporating oral algae-derived ω-3 FA supplementation (600 mg DHA/300 mg EPA week 1-8, 800 mg DHA/400 mg EPA week 8-16). At four visits (V1-V4), blood EPA/DHA levels were tracked using the HS-omega 3 index® (EPA/DHA (%) of total identified fatty acids in erythrocytes; target 8%-11%, deficit <8%, severe deficit <4%), alongside clinical assessments and standardized questionnaires. RESULTS At baseline, 98.3% of patients had an EPA/DHA deficit, with the mean HS-omega 3 index® rising from 4.9% at V1 to 8.3% at V4 (p < 0.001). AC showed significantly higher indices than AP at V4 (p = 0.035). Objective improvements in both inflammatory and non-inflammatory lesions were observed (p < 0.001). While self-reported appearance worsened in four patients, overall quality of life improved (p < 0.001), particularly in AP. Dietary triggers were more clearly defined than beneficial foods. Intake of cow's milk and dairy products reduced (p < 0.001). Compliance was good; no adverse events were reported. CONCLUSION Many acne patients have a ω-3 FA deficit. The HS-omega 3 index® can be increased by a Mediterranean diet and oral supplementation with algae-derived ω-3 FA. Acne severity improved significantly in patients with target ω-3 FA levels.
Collapse
Affiliation(s)
- Anne Guertler
- Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
| | - Katharina Neu
- Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
| | - Diana Lill
- Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
| | | | - Lars E French
- Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
- Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Coral Gables, USA
| | - Markus Reinholz
- Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
| |
Collapse
|
2
|
Huang HC, Lee IJ, Huang C, Chang TM. Lactic Acid Bacteria and Lactic Acid for Skin Health and Melanogenesis Inhibition. Curr Pharm Biotechnol 2020; 21:566-577. [DOI: 10.2174/1389201021666200109104701] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2019] [Revised: 07/26/2019] [Accepted: 12/11/2019] [Indexed: 12/21/2022]
Abstract
Lactic acid bacteria are beneficial to human health. Lactic acid bacteria have wide applications
in food, cosmetic and medicine industries due to being Generally Recognized As Safe (GRAS)
and a multitude of therapeutic and functional properties. Previous studies have reported the beneficial
effects of lactic acid bacteria, their extracts or ferments on skin health, including improvements in skin
conditions and the prevention of skin diseases. Lipoteichoic acid isolated from Lactobacillus plantarum
was reported to inhibit melanogenesis in B16F10 melanoma cells. In particular, lipoteichoic acid
also exerted anti-photoaging effects on human skin cells by regulating the expression of matrix metalloproteinase-
1. The oral administration of Lactobacillus delbrueckii and other lactic acid bacteria has
been reported to inhibit the development of atopic diseases. Additionally, the clinical and histologic
evidence indicates that the topical application of lactic acid is effective for depigmentation and improving
the surface roughness and mild wrinkling of the skin caused by environmental photo-damage. This
review discusses recent findings on the effects of lactic acid bacteria on skin health and their specific
applications in skin-whitening cosmetics.
Collapse
Affiliation(s)
- Huey-Chun Huang
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan
| | - I. Jung Lee
- Department of Kampo Medicine, Yokohama University of Pharmacy, Yokohama, Japan
| | - Chen Huang
- Office of Paradigm Industrial- Academic R & D Headquarter, Hungkuang University, Taichung, Taiwan
| | - Tsong-Min Chang
- Department of Applied Cosmetology, Hungkuang University, Taichung City, Taiwan
| |
Collapse
|
3
|
Balić A, Vlašić D, Žužul K, Marinović B, Bukvić Mokos Z. Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases. Int J Mol Sci 2020; 21:E741. [PMID: 31979308 PMCID: PMC7037798 DOI: 10.3390/ijms21030741] [Citation(s) in RCA: 120] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2019] [Revised: 01/20/2020] [Accepted: 01/21/2020] [Indexed: 12/19/2022] Open
Abstract
Omega-3 (ω-3) and omega-6 (ω-6) polyunsaturated fatty acids (PUFAs) are nowadays desirable components of oils with special dietary and functional properties. Their therapeutic and health-promoting effects have already been established in various chronic inflammatory and autoimmune diseases through various mechanisms, including modifications in cell membrane lipid composition, gene expression, cellular metabolism, and signal transduction. The application of ω-3 and ω-6 PUFAs in most common skin diseases has been examined in numerous studies, but their results and conclusions were mostly opposing and inconclusive. It seems that combined ω-6, gamma-linolenic acid (GLA), and ω-3 long-chain PUFAs supplementation exhibits the highest potential in diminishing inflammatory processes, which could be beneficial for the management of inflammatory skin diseases, such as atopic dermatitis, psoriasis, and acne. Due to significant population and individually-based genetic variations that impact PUFAs metabolism and associated metabolites, gene expression, and subsequent inflammatory responses, at this point, we could not recommend strict dietary and supplementation strategies for disease prevention and treatment that will be appropriate for all. Well-balanced nutrition and additional anti-inflammatory PUFA-based supplementation should be encouraged in a targeted manner for individuals in need to provide better management of skin diseases but, most importantly, to maintain and improve overall skin health.
Collapse
Affiliation(s)
- Anamaria Balić
- Department of Dermatology and Venereology, University Hospital Centre Zagreb, School of Medicine University of Zagreb, Šalata 4, 10 000 Zagreb, Croatia; (A.B.); (B.M.)
| | - Domagoj Vlašić
- Department of Ophtalmology and Optometry, General Hospital Dubrovnik, Ulica dr. Roka Mišetića 2, 20000 Dubrovnik, Croatia;
| | - Kristina Žužul
- School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia;
| | - Branka Marinović
- Department of Dermatology and Venereology, University Hospital Centre Zagreb, School of Medicine University of Zagreb, Šalata 4, 10 000 Zagreb, Croatia; (A.B.); (B.M.)
| | - Zrinka Bukvić Mokos
- Department of Dermatology and Venereology, University Hospital Centre Zagreb, School of Medicine University of Zagreb, Šalata 4, 10 000 Zagreb, Croatia; (A.B.); (B.M.)
| |
Collapse
|
4
|
|
5
|
Lee HC, Liang A, Lin YH, Guo YR, Huang SY. Low dietary n-6/n-3 polyunsaturated fatty acid ratio prevents induced oral carcinoma in a hamster pouch model. Prostaglandins Leukot Essent Fatty Acids 2018; 136:67-75. [PMID: 28292553 DOI: 10.1016/j.plefa.2017.03.003] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/09/2016] [Revised: 01/05/2017] [Accepted: 03/06/2017] [Indexed: 01/04/2023]
Abstract
Dietary fatty acid patterns have been linked to the prevalence of certain cancers, however in oral carcinoma is limited. Thus, we investigated the chemopreventive effects of various dietary n-6 and n-3 fatty acids in a 9,10-dimethyl-1,2-benz[a]-anthracene (DMBA)- and betel quid extract (BQE) -induced hamster oral cancer model. Thirty 6-week-old adult male hamsters were housed and divided into normal, low, and high dietary n-6 and n-3 fatty acid groups under DMBA + BQE treatment for 16 weeks. The right buccal pouch of all hamsters were evaluated by tumor number, volume, burden and selected inflammatory parameters. The results indicate that the low dietary n-6/n-3 fatty acid group exhibited a significantly lower tumor number, volume, and burden than those of the other groups. Furthermore, this group had significantly lower nuclear factor-κB, proliferating cell nuclear antigen, and cyclin D1 expression in the right buccal pouch tissue. In conclusion, the lower dietary n-6/n-3 fatty acid ratio exerted chemopreventive effects in the DMBA- and BQE-induced hamster oral cancer model.
Collapse
MESH Headings
- 9,10-Dimethyl-1,2-benzanthracene/toxicity
- Animals
- Anticarcinogenic Agents/administration & dosage
- Areca/chemistry
- Areca/toxicity
- Cricetinae
- Cyclin D1/metabolism
- Dose-Response Relationship, Drug
- Fatty Acids, Omega-3/administration & dosage
- Fatty Acids, Omega-3/pharmacology
- Fatty Acids, Omega-6/administration & dosage
- Fatty Acids, Omega-6/pharmacology
- Fatty Acids, Unsaturated/administration & dosage
- Fatty Acids, Unsaturated/pharmacology
- Gene Expression Regulation, Neoplastic/drug effects
- Male
- Mouth Neoplasms/chemically induced
- Mouth Neoplasms/diet therapy
- Mouth Neoplasms/metabolism
- NF-kappa B/metabolism
- Plant Extracts/toxicity
- Proliferating Cell Nuclear Antigen/metabolism
- Tumor Burden/drug effects
- Xenograft Model Antitumor Assays
Collapse
Affiliation(s)
- Hsiu-Chuan Lee
- School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan
| | - An Liang
- School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan
| | - Yun-Ho Lin
- Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan
| | - Yu-Ru Guo
- School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan
| | - Shih-Yi Huang
- School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei, Taiwan; Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
| |
Collapse
|
6
|
Crucian BE, Choukèr A, Simpson RJ, Mehta S, Marshall G, Smith SM, Zwart SR, Heer M, Ponomarev S, Whitmire A, Frippiat JP, Douglas GL, Lorenzi H, Buchheim JI, Makedonas G, Ginsburg GS, Ott CM, Pierson DL, Krieger SS, Baecker N, Sams C. Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration Missions. Front Immunol 2018; 9:1437. [PMID: 30018614 PMCID: PMC6038331 DOI: 10.3389/fimmu.2018.01437] [Citation(s) in RCA: 191] [Impact Index Per Article: 31.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2018] [Accepted: 06/11/2018] [Indexed: 12/11/2022] Open
Abstract
Recent studies have established that dysregulation of the human immune system and the reactivation of latent herpesviruses persists for the duration of a 6-month orbital spaceflight. It appears certain aspects of adaptive immunity are dysregulated during flight, yet some aspects of innate immunity are heightened. Interaction between adaptive and innate immunity also seems to be altered. Some crews experience persistent hypersensitivity reactions during flight. This phenomenon may, in synergy with extended duration and galactic radiation exposure, increase specific crew clinical risks during deep space exploration missions. The clinical challenge is based upon both the frequency of these phenomena in multiple crewmembers during low earth orbit missions and the inability to predict which specific individual crewmembers will experience these changes. Thus, a general countermeasure approach that offers the broadest possible coverage is needed. The vehicles, architecture, and mission profiles to enable such voyages are now under development. These include deployment and use of a cis-Lunar station (mid 2020s) with possible Moon surface operations, to be followed by multiple Mars flyby missions, and eventual human Mars surface exploration. Current ISS studies will continue to characterize physiological dysregulation associated with prolonged orbital spaceflight. However, sufficient information exists to begin consideration of both the need for, and nature of, specific immune countermeasures to ensure astronaut health. This article will review relevant in-place operational countermeasures onboard ISS and discuss a myriad of potential immune countermeasures for exploration missions. Discussion points include nutritional supplementation and functional foods, exercise and immunity, pharmacological options, the relationship between bone and immune countermeasures, and vaccination to mitigate herpes (and possibly other) virus risks. As the immune system has sentinel connectivity within every other physiological system, translational effects must be considered for all potential immune countermeasures. Finally, we shall discuss immune countermeasures in the context of their individualized implementation or precision medicine, based on crewmember specific immunological biases.
Collapse
Affiliation(s)
- Brian E. Crucian
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, United States
| | - Alexander Choukèr
- Laboratory of Translational Research “Stress and Immunity”, Department of Anesthesiology, Hospital of the Ludwig-Maximilians-University, Munich, Germany
| | - Richard J. Simpson
- Department of Nutritional Sciences, The University of Arizona, Tucson, AZ, United States
- Department of Pediatrics, The University of Arizona, Tucson, AZ, United States
- Department of Immunobiology, The University of Arizona, Tucson, AZ, United States
| | | | - Gailen Marshall
- University of Mississippi Medical Center, Jackson, MS, United States
| | - Scott M. Smith
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, United States
| | - Sara R. Zwart
- University of Texas Medical Branch, Galveston, TX, United States
| | - Martina Heer
- Institute of Nutritional and Food Sciences, University of Bonn, Bonn, Germany
| | | | | | - Jean P. Frippiat
- Stress Immunity Pathogens Laboratory, EA7300, Lorraine University, Nancy, France
| | - Grace L. Douglas
- Human Systems Engineering and Development Division, NASA Johnson Space Center, Houston, TX, United States
| | | | - Judith-Irina Buchheim
- Laboratory of Translational Research “Stress and Immunity”, Department of Anesthesiology, Hospital of the Ludwig-Maximilians-University, Munich, Germany
| | | | - Geoffrey S. Ginsburg
- Duke Center for Applied Genomics and Precision Medicine, Durham, NC, United States
| | - C. Mark Ott
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, United States
| | - Duane L. Pierson
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, United States
| | | | - Natalie Baecker
- Institute of Nutritional and Food Sciences, University of Bonn, Bonn, Germany
| | - Clarence Sams
- Biomedical Research and Environmental Sciences Division, NASA Johnson Space Center, Houston, TX, United States
| |
Collapse
|
7
|
Jung TD, Choi SI, Choi SH, Cho BY, Sim WS, Xionggao H, Lee SJ, Park SJ, Kim DB, Kim YC, Lee JH, Lee OH. Changes in the Anti-Allergic Activities of Sesame by Bioconversion. Nutrients 2018; 10:E210. [PMID: 29443928 PMCID: PMC5852786 DOI: 10.3390/nu10020210] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2017] [Revised: 02/12/2018] [Accepted: 02/13/2018] [Indexed: 01/02/2023] Open
Abstract
Sesame is an important oilseed crop, which has been used as a traditional health food to ameliorate the prevention of various diseases. We evaluated the changes in the anti-allergic activities of sesame by bioconversion. SDS-PAGE of non-fermented sesame proteins showed major allergen bands, while that of fermented sesame showed only a few protein bands. Additionally, we investigated the effectiveness of fermented sesame by bioconversion in tumor necrosis factor-α (TNF-α)- and interferon-γ (IFN-γ)-induced HaCaT cells. In HaCaT cells, fermented sesame inhibited the mRNA expression of interleukin-6 (IL-6) and interleukin-1β (IL-1β), thymus and macrophage-derived chemokine (MDC/CCL22), activation-regulated chemokine (TARC/CCL17), and intercellular adhesion molecule-1 (ICAM-1). Moreover, fermented sesame inhibited the activation of nuclear factor-κB (NF-κB) and signal transducer and activator of transcription 1 (STAT1). Fermented sesame exerts anti-allergic effects by suppressing the expression of chemokines and cytokines via blockade of NF-κB and STAT1 activation.
Collapse
MESH Headings
- Agaricales
- Allergens/adverse effects
- Allergens/analysis
- Allergens/metabolism
- Cell Line
- Chemokines/antagonists & inhibitors
- Chemokines/genetics
- Chemokines/metabolism
- Crops, Agricultural/adverse effects
- Crops, Agricultural/chemistry
- Crops, Agricultural/growth & development
- Crops, Agricultural/microbiology
- Cytokines/antagonists & inhibitors
- Cytokines/genetics
- Cytokines/metabolism
- Dermatitis, Atopic/etiology
- Dermatitis, Atopic/immunology
- Dermatitis, Atopic/prevention & control
- Fermentation
- Fermented Foods/adverse effects
- Fermented Foods/analysis
- Fermented Foods/microbiology
- Food Handling
- Food Hypersensitivity/etiology
- Food Hypersensitivity/immunology
- Food Hypersensitivity/prevention & control
- Fruiting Bodies, Fungal
- Gene Expression Regulation, Neoplastic
- Humans
- Keratinocytes/immunology
- Keratinocytes/metabolism
- Plant Proteins, Dietary/adverse effects
- Plant Proteins, Dietary/analysis
- Plant Proteins, Dietary/metabolism
- Republic of Korea
- Seeds/adverse effects
- Seeds/chemistry
- Seeds/growth & development
- Seeds/microbiology
- Sesamum/adverse effects
- Sesamum/chemistry
- Sesamum/growth & development
- Sesamum/microbiology
- Shiitake Mushrooms/isolation & purification
- Shiitake Mushrooms/metabolism
Collapse
Affiliation(s)
- Tae-Dong Jung
- Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Korea; (T.-D.J.); (S.-I.C.); (S.-H.C.); (B.-Y.C.); (W.-S.S.); (H.-X.)
| | - Sun-Il Choi
- Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Korea; (T.-D.J.); (S.-I.C.); (S.-H.C.); (B.-Y.C.); (W.-S.S.); (H.-X.)
| | - Seung-Hyun Choi
- Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Korea; (T.-D.J.); (S.-I.C.); (S.-H.C.); (B.-Y.C.); (W.-S.S.); (H.-X.)
| | - Bong-Yeon Cho
- Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Korea; (T.-D.J.); (S.-I.C.); (S.-H.C.); (B.-Y.C.); (W.-S.S.); (H.-X.)
| | - Wan-Sup Sim
- Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Korea; (T.-D.J.); (S.-I.C.); (S.-H.C.); (B.-Y.C.); (W.-S.S.); (H.-X.)
| | - Han- Xionggao
- Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Korea; (T.-D.J.); (S.-I.C.); (S.-H.C.); (B.-Y.C.); (W.-S.S.); (H.-X.)
| | - Sang Jong Lee
- STR Biotech Company, LTD., Chuncheon 24232, Korea; or l (S.J.L.); (S.J.P.)
| | - Seon Ju Park
- STR Biotech Company, LTD., Chuncheon 24232, Korea; or l (S.J.L.); (S.J.P.)
| | - Dan-Bi Kim
- Korea Food Research Institute, Wanju-gun, Jeollabuk-do 55365, Korea;
| | - Young-Cheul Kim
- Department of Nutrition, University of Massachusetts Amherst, Amherst, MA 01003, USA;
| | - Jin-Ha Lee
- Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Korea; (T.-D.J.); (S.-I.C.); (S.-H.C.); (B.-Y.C.); (W.-S.S.); (H.-X.)
| | - Ok-Hwan Lee
- Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Korea; (T.-D.J.); (S.-I.C.); (S.-H.C.); (B.-Y.C.); (W.-S.S.); (H.-X.)
| |
Collapse
|
8
|
Tkachenko N, Chagarovskyi O, Dets N, Sevastyanova E, Lanzhenko L. “Lving” and “probiotic” cosmetics: modern view and defenitions. FOOD SCIENCE AND TECHNOLOGY 2017. [DOI: 10.15673/fst.v11i4.735] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
In the presented article, based on the detailed analysis of scientific sources and many years of own experience in production of the probiotic foods, the definition of “probiotics” in cosmetics, as well as the definition of “living” and “probiotic” cosmetics is proposed.The skin is a complex barrier organ that has a symbiotic relationship between microbial communities and host tissue via complex signals provided by the innate and the adaptive immune systems. It is constantly exposed to various endogenous and exogenous factors – physical, chemical, bacterial and fungal, as well as the effects of the hormonal disorders, which affect this balanced system potentially leading to inflammatory skin conditions comprising infections, allergies or autoimmune diseases. In opposition to the gut and stool microbiome, which has been studied and described for many years, investigations on the skin or scalp microbiome lasts only for last 10 years. Therefore, the screening of effective means of correcting and/or maintaining the human normoflora for the preservation of healthy skin microbiome today is an urgent task.It is well known that probiotics and prebiotics are helpful for specific disorders in the human body. Skeptics wonder: can the probiotics and prebiotics be scientifically applied in cosmetics? Different clinical studies indicated that they have special effects in cutaneous apparatus directly or indirectly, which can be considered from different aspects. Probiotic bacteriotherapy can have great potential in accelerating wound healing, in preventing and treating the skin diseases including eczema, atopic dermatitis, acne, allergic inflammation or skin hypersensitivity, UV-induced skin damage and cosmetics products. Therefore, some firms are already incorporating bacteria and/or their lysates into skin creams with the promise of «rebalancing» the community of bacteria that live in the human body and delivering healthier, more radiant-looking skin. However, such parameters as the type of probiotic, the form in which it is added to the formulation (living bacteria, lysates, etc.) and the recommended concentrations of these ingredients in cosmetic products that are safe and effective are still not defined. Due to currently widespread use of probiotic cosmetic products in the world beauty industry, the concept of "probiotic" in the cosmetic industry requires a clear definition.
Collapse
|
9
|
Zhang P, Wu C, Huang XH, Shen CL, Li L, Zhang W, Yao CZ. Aspirin suppresses TNF-α-induced MMP-9 expression via NF-κB and MAPK signaling pathways in RAW264.7 cells. Exp Ther Med 2017; 14:5597-5604. [PMID: 29285098 DOI: 10.3892/etm.2017.5252] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2016] [Accepted: 02/14/2017] [Indexed: 12/31/2022] Open
Abstract
Numerous studies have indicated that the expression of matrix metalloproteinase-9 (MMP-9) contributes to the atherosclerotic plaque hemorrhage and rupture. Aspirin, a non-steroidal anti-inflammation drug, has been known for its anti-platelet effect in the prevention of the vascular complications of atherosclerosis. The present study aimed to investigate the pharmacological effects of aspirin on tumor necrosis factor-α (TNF-α)-induced MMP-9 expression and the underlying molecular mechanisms in murine macrophage RAW264.7 cells. Western blot analysis indicated that the protein level of MMP-9 was reduced by aspirin in a dose-dependent manner. In addition, downregulation of MMP-9 mRNA and activity were detected in aspirin-treated cells using quantitative polymerase chain reaction and a gelatin zymography assay separately. It was also observed that aspirin has a suppressive effect on the activation of nuclear factor (NF)-κB and inhibits the phosphorylation of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinases 1/2, p38 and c-Jun N-terminal kinase. Furthermore, subsequent to inhibition of the MAPK pathway by specific inhibitors (PD98059, SB203580 and SP600125), the expression of MMP-9 was reduced, indicating that the inhibitory effect of aspirin on MMP-9 in TNF-α-treated RAW264.7 cells may be, at least in part, through suppression of NF-κB activation and the MAPK pathway. These findings support the notion that aspirin has therapeutic potential application in the prevention and treatment of atherosclerosis disease.
Collapse
Affiliation(s)
- Ping Zhang
- Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China.,Department of Pharmacy, Chenjian Hospital of Hefei City, Hefei, Anhui 230041, P.R. China
| | - Chao Wu
- Department of Pharmacology and Institute of Natural Medicine, Anhui Medical University, Hefei, Anhui 230032, P.R. China
| | - Xiao-Hui Huang
- Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China
| | - Chen-Lin Shen
- Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China
| | - Lin Li
- Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China
| | - Wei Zhang
- Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China
| | - Cheng-Zeng Yao
- Department of Cardiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, P.R. China
| |
Collapse
|
10
|
Abstract
Human skin is the first defense barrier against the external environment, especially microbial pathogens and physical stimulation. Many studies on skin health with Lactic acid bacteria (LAB) have been published for many years, including prevention of skin disease and improvement of skin conditions. LAB, a major group of gram-positive bacteria, are known to be beneficial to human health by acting as probiotics. Recent studies have shown that LAB and their extracts have beneficial effects on maintenance and improvement of skin health. Oral administration of Lactobacillus delbrueckii inhibits the development of atopic disease. In addition, LAB and LAB extracts are known to have beneficial effects on intestinal diseases, with Lactobacillus plantarum having been shown to attenuate IL-10 deficient colitis. In addition to intestinal health, L. plantarum also has beneficial effects on skin. pLTA, which is lipoteichoic acid isolated from L. plantarum, has anti-photoaging effects on human skin cells by regulating the expression matrix meralloprotionase-1 (MMP-1) expression. While several studies have proposed a relationship between diseases of the skin and small intestines, there are currently no published reviews of the effects of LAB for skin health through regulation of intestinal conditions and the immune system. In this review, we discuss recent findings on the effects of LAB on skin health and its potential applications in beauty foods.
Collapse
Affiliation(s)
- Ji Hye Jeong
- a Skin Biotechnology Center, Kyung Hee University , Yongin , South Korea
| | - Chang Y Lee
- b Department of Food Science , Cornell University , Ithaca , New York USA
| | - Dae Kyun Chung
- a Skin Biotechnology Center, Kyung Hee University , Yongin , South Korea.,b Department of Food Science , Cornell University , Ithaca , New York USA.,c School of Biotechnology and Institute of Life Science and Resources, Kyung Hee University , Yongin , South Korea.,d RNA Inc., College of Life Science, Kyung Hee University , South Korea
| |
Collapse
|
11
|
Decreased eicosapentaenoic acid levels in acne vulgaris reveals the presence of a proinflammatory state. Prostaglandins Other Lipid Mediat 2017; 128-129:1-7. [DOI: 10.1016/j.prostaglandins.2016.12.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2016] [Revised: 12/21/2016] [Accepted: 12/22/2016] [Indexed: 12/19/2022]
|
12
|
Udommethaporn S, Tencomnao T, McGowan EM, Boonyaratanakornkit V. Assessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug Screening. PLoS One 2016; 11:e0159151. [PMID: 27415000 PMCID: PMC4945017 DOI: 10.1371/journal.pone.0159151] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2016] [Accepted: 06/10/2016] [Indexed: 12/26/2022] Open
Abstract
Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory cytokine important in normal and pathological biological processes. Newly synthesized pro-TNF-α is expressed on the plasma membrane and cleaved to release soluble TNF-α protein: both are biologically active. Secreted TNF-α signals through TNF receptors and the membrane-bound TNF-α acts by cell contact-dependent signaling. Anti-TNF-α antibodies have been used effectively for treatment of chronic inflammation, however with adverse side effects. Thus, there is a need for new anti-TNF-α small molecule compounds. Anti-TNF-α activity assays involve treatment of keratinocytes with exogenous TNF-α before or after anti-TNF-α incubation. However, this model fails to address the dual signaling of TNF-α. Here we describe a Doxycycline (Dox)-inducible TNF-α (HaCaT-TNF-α) expression system in keratinocytes. Using this in-vitro model, we show cell inhibition and induced expression of pro-inflammatory cytokines and markers, including IL-1β, IL-6, IL-8, NF-κB1, and KRT-16, similar to cells treated with exogenous TNF-α. Sufficient secreted TNF-α produced also activated IL-1β and IL-8 expression in wt HaCaT cells. Importantly, stimulated expression of IL-1β and IL-8 in HaCaT-TNF-α were blocked by Quercetin, a flavanol shown to possess anti-TNF-α activities. This novel in vitro cell model provides an efficient tool to investigate the dual signaling of TNF-α. Importantly, this model provides an effective, fast, and simple screening for compounds with anti-TNF-α activities for chronic inflammatory disease therapies.
Collapse
Affiliation(s)
- Sutthirat Udommethaporn
- Graduate Program in Clinical Biochemistry and Molecular Medicine, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
| | - Tewin Tencomnao
- Graduate Program in Clinical Biochemistry and Molecular Medicine, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.,Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
| | - Eileen M McGowan
- Chronic Disease Solutions Team, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, Sydney, Australia
| | - Viroj Boonyaratanakornkit
- Graduate Program in Clinical Biochemistry and Molecular Medicine, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.,Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
| |
Collapse
|
13
|
Yokoyama S, Hiramoto K, Koyama M, Ooi K. Chronic liver injury in mice promotes impairment of skin barrier function via tumor necrosis factor-alpha. Cutan Ocul Toxicol 2015; 35:194-203. [PMID: 26362357 DOI: 10.3109/15569527.2015.1076433] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
CONTEXT Alcohol is frequently used to induce chronic liver injury in laboratory animals. Alcohol causes oxidative stress in the liver and increases the expression of inflammatory mediators that cause hepatocellular damage. However, during chronic liver injury, it is unclear if/how these liver-derived factors affect distal tissues, such as the skin. OBJECTIVE The purpose of this study was to evaluate skin barrier function during chronic liver injury. MATERIALS AND METHODS Hairless mice were administered 5% or 10% ethanol for 8 weeks, and damages to the liver and skin were assessed using histological and protein-analysis methods, as well as by detecting inflammatory mediators in the plasma. RESULTS After alcohol administration, the plasma concentration of the aspartate and alanine aminotransferases increased, while albumin levels decreased. In mice with alcohol-induced liver injury, transepidermal water loss was significantly increased, and skin hydration decreased concurrent with ceramide and type I collagen degradation. The plasma concentrations of [Formula: see text]/[Formula: see text] and tumor necrosis factor-alpha (TNF-α) were significantly increased in mice with induced liver injury. TNF receptor (TNFR) 2 expression was upregulated in the skin of alcohol-administered mice, while TNFR1 levels remained constant. Interestingly, the impairment of skin barrier function in mice administered with 10% ethanol was ameliorated by administering an anti-TNF-α antibody. CONCLUSIONS We propose a novel mechanism whereby plasma TNF-α, via TNFR2 alone or with TNFR1, plays an important role in skin barrier function during chronic liver disease in these mouse models.
Collapse
Affiliation(s)
- Satoshi Yokoyama
- a Faculty of Pharmaceutical Sciences , Suzuka University of Medical Science , Suzuka , Japan
| | - Keiichi Hiramoto
- a Faculty of Pharmaceutical Sciences , Suzuka University of Medical Science , Suzuka , Japan
| | - Mayu Koyama
- a Faculty of Pharmaceutical Sciences , Suzuka University of Medical Science , Suzuka , Japan
| | - Kazuya Ooi
- a Faculty of Pharmaceutical Sciences , Suzuka University of Medical Science , Suzuka , Japan
| |
Collapse
|
14
|
Levels of Cytokines and Matrix Metalloproteinases 2 and 9 in the Synovial Fluid of Osteoarthritic Horses Treated With Pamidronate. J Equine Vet Sci 2015. [DOI: 10.1016/j.jevs.2015.03.194] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
15
|
Palomino-Morales R, Alejandre MJ, Perales S, Torres C, Linares A. Effect of PUFAs on extracellular matrix production and remodeling in vascular smooth muscle cell cultures in an atherosclerotic model. EUR J LIPID SCI TECH 2014. [DOI: 10.1002/ejlt.201400141] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Rogelio Palomino-Morales
- Faculty of Sciences, Department of Biochemistry and Molecular Biology I; Campus Universitario de Fuentenueva, University of Granada; Granada Spain
| | - M. Jose Alejandre
- Faculty of Sciences, Department of Biochemistry and Molecular Biology I; Campus Universitario de Fuentenueva, University of Granada; Granada Spain
| | - Sonia Perales
- Faculty of Sciences, Department of Biochemistry and Molecular Biology I; Campus Universitario de Fuentenueva, University of Granada; Granada Spain
| | - Carolina Torres
- Faculty of Sciences, Department of Biochemistry and Molecular Biology I; Campus Universitario de Fuentenueva, University of Granada; Granada Spain
| | - Ana Linares
- Faculty of Sciences, Department of Biochemistry and Molecular Biology I; Campus Universitario de Fuentenueva, University of Granada; Granada Spain
| |
Collapse
|
16
|
Taguchi A, Kawana K, Tomio K, Yamashita A, Isobe Y, Nagasaka K, Koga K, Inoue T, Nishida H, Kojima S, Adachi K, Matsumoto Y, Arimoto T, Wada-Hiraike O, Oda K, Kang JX, Arai H, Arita M, Osuga Y, Fujii T. Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo. PLoS One 2014; 9:e89605. [PMID: 24586907 PMCID: PMC3937340 DOI: 10.1371/journal.pone.0089605] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2013] [Accepted: 01/22/2014] [Indexed: 12/22/2022] Open
Abstract
Cancer associated fibroblasts (CAFs) are responsible for tumor growth, angiogenesis, invasion, and metastasis. Matrix metalloproteinase (MMP)-9 secreted from cancer stroma populated by CAFs is a prerequisite for cancer angiogenesis and metastasis. Omega-3 polyunsaturated fatty acids (omega-3 PUFA) have been reported to have anti-tumor effects on diverse types of malignancies. Fat-1 mice, which can convert omega-6 to omega-3 PUFA independent of diet, are useful to investigate the functions of endogenous omega-3 PUFA. To examine the effect of omega-3 PUFA on tumorigenesis, TC-1 cells, a murine epithelial cell line immortalized by human papillomavirus (HPV) oncogenes, were injected subcutaneously into fat-1 or wild type mice. Tumor growth and angiogenesis of the TC-1 tumor were significantly suppressed in fat-1 compared to wild type mice. cDNA microarray of the tumors derived from fat-1 and wild type mice revealed that MMP-9 is downregulated in fat-1 mice. Immunohistochemical study demonstrated immunoreactivity for MMP-9 in the tumor stromal fibroblasts was diffusely positive in wild type whereas focal in fat-1 mice. MMP-9 was expressed in primary cultured fibroblasts isolated from fat-1 and wild type mice but was not expressed in TC-1 cells. Co-culture of fibroblasts with TC-1 cells enhanced the expression and the proteinase activity of MMP-9, although the protease activity of MMP-9 in fat-1-derived fibroblasts was lower than that in wild type fibroblasts. Our data suggests that omega-3 PUFAs suppress MMP-9 induction and tumor angiogenesis. These findings may provide insight into mechanisms by which omega-3 PUFAs exert anti-tumor effects by modulating tumor microenvironment.
Collapse
Affiliation(s)
- Ayumi Taguchi
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Kei Kawana
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
- * E-mail: (K. Kawana); (MA)
| | - Kensuke Tomio
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Aki Yamashita
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Yosuke Isobe
- Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Kazunori Nagasaka
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Kaori Koga
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Tomoko Inoue
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Haruka Nishida
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Satoko Kojima
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Katsuyuki Adachi
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Yoko Matsumoto
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Takahide Arimoto
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Osamu Wada-Hiraike
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Katsutoshi Oda
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Jing X. Kang
- Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America
| | - Hiroyuki Arai
- Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Makoto Arita
- Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
- * E-mail: (K. Kawana); (MA)
| | - Yutaka Osuga
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| | - Tomoyuki Fujii
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
| |
Collapse
|
17
|
Experimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases. BIOMED RESEARCH INTERNATIONAL 2013; 2013:743171. [PMID: 23691510 PMCID: PMC3652138 DOI: 10.1155/2013/743171] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/01/2013] [Revised: 03/27/2013] [Accepted: 03/27/2013] [Indexed: 12/19/2022]
Abstract
A large body of evidence has emerged over the past years to show the critical role played by inflammation in the pathogenesis of several diseases including some cardiovascular, neoplastic, and neurodegenerative diseases, previously not considered inflammation-related. The anti-inflammatory action of ω-3 polyunsaturated fatty acids (PUFAs), as well as their potential healthy effects against the development and progression of the same diseases, has been widely studied by our and others' laboratories. As a result, a rethinking is taking place on the possible mechanisms underlying the beneficial effects of ω-3 PUFAs against these disorders, and, in particular, on the influence that they may exert on the molecular pathways involved in inflammatory process, including the production of inflammatory cytokines and lipid mediators active in the resolving phase of inflammation. In the present review we will summarize and discuss the current knowledge regarding the modulating effects of ω-3 PUFAs on the production of inflammatory cytokines and proresolving or protective lipid mediators in the context of inflammatory, metabolic, neurodegenerative, and neoplastic diseases.
Collapse
|
18
|
Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt JP. Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men. Nutr Metab (Lond) 2012; 9:45. [PMID: 22621246 PMCID: PMC3408332 DOI: 10.1186/1743-7075-9-45] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2012] [Accepted: 05/23/2012] [Indexed: 12/31/2022] Open
Abstract
Background The beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs), especially in dyslipidemic subjects with a high risk of cardiovascular disease, are widely described in the literature. A lot of effects of n-3 PUFAs and their oxidized metabolites are triggered by regulating the expression of genes. Currently, it is uncertain if the administration of n-3 PUFAs results in different expression changes of genes related to antioxidative mechanisms in normo- and dyslipidemic subjects, which may partly explain their cardioprotective effects. The aim of this study was to investigate the effects of n-3 PUFA supplementation on expression changes of genes involved in oxidative processes. Methods Ten normo- and ten dyslipidemic men were supplemented for twelve weeks with fish oil capsules, providing 1.14 g docosahexaenoic acid and 1.56 g eicosapentaenoic acid. Gene expression levels were determined by whole genome microarray analysis and quantitative real-time polymerase chain reaction (qRT-PCR). Results Using microarrays, we discovered an increased expression of antioxidative enzymes and a decreased expression of pro-oxidative and tissue enzymes, such as cytochrome P450 enzymes and matrix metalloproteinases, in both normo- and dyslipidemic men. An up-regulation of catalase and heme oxigenase 2 in both normo- and dyslipidemic subjects and an up-regulation of cytochrome P450 enzyme 1A2 only in dyslipidemic subjects could be observed by qRT-PCR analysis. Conclusions Supplementation of normo- and dyslipidemic subjects with n-3 PUFAs changed the expression of genes related to oxidative processes, which may suggest antioxidative and potential cardioprotective effects of n-3 PUFAs. Further studies combining genetic and metabolic endpoints are needed to verify the regulative effects of n-3 PUFAs in antioxidative gene expression to better understand their beneficial effects in health and disease prevention. Trial registration ClinicalTrials.gov (ID: NCT01089231)
Collapse
Affiliation(s)
- Simone Schmidt
- Faculty of Natural Sciences at the Leibniz University of Hannover, Institute of Food Science and Human Nutrition, Am Kleinen Felde 30, 30167, Hannover, Germany
| | - Frank Stahl
- Faculty of Natural Sciences at the Leibniz University of Hannover, Institute of Technical Chemistry, Callinstr 5, 30167, Hannover, Germany
| | - Kai-Oliver Mutz
- Faculty of Natural Sciences at the Leibniz University of Hannover, Institute of Technical Chemistry, Callinstr 5, 30167, Hannover, Germany
| | - Thomas Scheper
- Faculty of Natural Sciences at the Leibniz University of Hannover, Institute of Technical Chemistry, Callinstr 5, 30167, Hannover, Germany
| | - Andreas Hahn
- Faculty of Natural Sciences at the Leibniz University of Hannover, Institute of Food Science and Human Nutrition, Am Kleinen Felde 30, 30167, Hannover, Germany
| | - Jan Philipp Schuchardt
- Faculty of Natural Sciences at the Leibniz University of Hannover, Institute of Food Science and Human Nutrition, Am Kleinen Felde 30, 30167, Hannover, Germany
| |
Collapse
|
19
|
The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model. Life Sci 2012; 90:934-43. [PMID: 22569299 DOI: 10.1016/j.lfs.2012.04.029] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2011] [Revised: 04/17/2012] [Accepted: 04/21/2012] [Indexed: 11/24/2022]
Abstract
AIMS Eicosapentaenoic acid (EPA) can ameliorate certain liver lesions involved in non-alcoholic steatohepatitis (NASH). A previous study has found that stroke-prone spontaneously hypertensive 5/Dmcr (SHRSP5/Dmcr) rats fed a high fat-cholesterol (HFC) diet developed fibrotic steatohepatitis with histological similarities to NASH. This study evaluated the potential effects and mechanisms of action of EPA supplementation using this rodent model. MAIN METHODS Male rats were randomly assigned to groups that were fed with either the stroke-prone (SP) diet or HFC diet with or without EPA for 2, 8 and 14 weeks, respectively. The liver histopathology, biochemical features, mRNA and protein levels, and nuclear factor-κB (NF-κB) DNA binding activity were determined. KEY FINDINGS The SP diet-fed rats presented normal livers. Conversely, the HFC diet-fed rats developed microvesicular/macrovesicular steatosis, inflammation, ballooning degeneration and severe fibrosis. At 2 weeks, the administration of EPA inhibited hepatic inflammatory recruitment by blocking the phosphorylation of inhibitor of κB-α (IκBα), which antagonizes the NF-κB activation pathway. The dietary supplementation of EPA for 8 weeks ameliorated hepatic triglyceride accumulation and macrovesicular steatosis by inhibiting the HFC diet-induced decrease in the protein levels of enzymes involved in fatty acid β-oxidation including carnitine palmitoyltransferase 1, very long chain acyl-CoA dehydrogenase and peroxisomal bifunctional protein. Although the administration of EPA elicited no histologically detectable effects on severe fibrosis at 14 weeks, it restored an HFC diet-induced decline in hepatic adenosine triphosphate (ATP) levels and suppressed ballooning degeneration, suggesting that EPA may inhibit HFC diet-induced ATP loss and cell death. SIGNIFICANCE Initial amelioration of the inflammation and steatosis in the rats after EPA supplementation indicates a possibility to treat steatohepatitis. Additionally, this study provides new insights into the roles of EPA in hepatic ATP depletion and subsequent hepatocellular injury during severe fibrosis.
Collapse
|
20
|
Yang H, Dai Y, Dong H, Zang D, Liu Q, Duan H, Niu Y, Bin P, Zheng Y. Trichloroethanol up-regulates matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in HaCaT cells. Toxicol In Vitro 2011; 25:1638-43. [DOI: 10.1016/j.tiv.2011.06.015] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2011] [Accepted: 06/22/2011] [Indexed: 11/25/2022]
|
21
|
Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial. Nutrition 2011; 28:623-9. [PMID: 22113064 DOI: 10.1016/j.nut.2011.08.004] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2011] [Accepted: 08/15/2011] [Indexed: 12/18/2022]
Abstract
OBJECTIVE Compared with soybean oil, a fish oil-enriched emulsion can improve the clinical outcomes of patients requiring parenteral nutrition. However, the superiority of fish oil emulsion to medium-chain triacylglycerols/long-chain triacylglycerols for short-term administration has seldom been discussed. METHODS Sixty-four adult patients with gastrointestinal diseases were randomly assigned to receive isocaloric and isonitrogenous total parenteral nutrition with an ω-3 fatty acid-enriched emulsion (Lipoplus; study group, n = 32) or medium-chain triacylglycerols/long-chain triacylglycerols (Lipofundin; control group, n = 32) for 5 d after surgery. Safety and efficacy parameters were assessed on postoperative days 1, 3, and 6. RESULTS Clinical outcomes including infectious complications and systemic inflammatory response syndrome were comparable between the two groups. Total bilirubin decreased over time in the study group versus an increase in the control group (P = 0.017). Activated partial thromboplastin time in the study group was prolonged significantly compared with the control group from days 1 to 3 (P = 0.002), although the prolongation stopped at the study termination. There were no differences in changes of C-reactive protein, interleukin (IL)-1, IL-8, IL-10, vascular endothelial growth factor (VEGF), and the distribution of the T-cell subpopulation between the two groups. However, fish oil consumption led to an increase in leukotriene B5/ leukotriene B4 and significant decreases in IL-6, tumor necrosis factor-α, and nuclear factor-κB. Furthermore, the overall changes in tumor necrosis factor-α and nuclear factor-κB were positively associated (R(2) = 0.295, P < 0.001). CONCLUSIONS Gastrointestinal surgery patients benefited from a fish oil-enriched emulsion rather than medium-chain triacylglycerols/long-chain triacylglycerols in the amelioration of liver function and immune status. The positive association of tumor necrosis factor-α and nuclear factor-κB might be involved in the potential anti-inflammation mechanism of fish oil.
Collapse
|
22
|
Takase O, Hishikawa K, Kamiura N, Nakakuki M, Kawano H, Mizuguchi K, Fujita T. Eicosapentaenoic acid regulates IκBα and prevents tubulointerstitial injury in kidney. Eur J Pharmacol 2011; 669:128-35. [PMID: 21871881 DOI: 10.1016/j.ejphar.2011.07.043] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2010] [Revised: 07/18/2011] [Accepted: 07/29/2011] [Indexed: 11/28/2022]
Abstract
Fish oil containing n-3 polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is well known to prevent the progression of IgA nephropathy. However, the mechanism through which fish oil prevents the progression of renal injury remains uncertain. We tried to clarify the effects of EPA on tubulointerstitial injury in the kidney both in vivo and in vitro. We examined the effects of EPA, especially to focus on nuclear factor kappa B (NF-κB), using Thy-1 nephritis models. Also the mechanism of EPA was investigated using small-interfering RNA (siRNA) in lipopolysaccharide (LPS)-stimulated proximal tubular epithelial cells (PTECs). In Thy-1 nephritis models, EPA significantly inhibited tubulointerstitial injury and the infiltration of macrophages into tubulointerstitial lesions except severe glomerular injury at early stage. Compared with control animals, NF-κB activation was significantly augmented in the Thy-1 nephritic kidney. However, treatment with EPA significantly reduced NF-κB activation, down-regulated the expressions of NF-κB-dependent molecules. Also in LPS-stimulated PTECs, LPS augmented NF-κB activation and the expression of NF-κB-dependent molecules. As in the case with the Thy-1 nephritis models, treatment with EPA inhibited them, prevented the degradation of IκBα in LPS-stimulated PTECs. Pre-treatment with siRNA for IκBα abolished the inhibitory effect of EPA on LPS-induced NF-κB activation, suggesting that EPA inhibited NF-κB activation by regulating IκBα. Our results indicate that EPA prevents the early progression of tubulointerstitial injury in Thy-1 nephritis models, and the inhibitory effect of EPA on the expression of inflammatory molecules via the regulation of IκBα in cultured cells may explain this mechanism.
Collapse
Affiliation(s)
- Osamu Takase
- Department of Clinical Renal Regeneration, and Division of Nephrology and Endocrinology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
| | | | | | | | | | | | | |
Collapse
|
23
|
Song HY, Ju SM, Goh AR, Kwon DJ, Choi SY, Park JS. Suppression of TNF-alpha-induced MMP-9 expression by a cell-permeable superoxide dismutase in keratinocytes. BMB Rep 2011; 44:462-7. [DOI: 10.5483/bmbrep.2011.44.7.462] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
24
|
Rondeau I, Picard S, Bah TM, Roy L, Godbout R, Rousseau G. Effects of different dietary omega-6/3 polyunsaturated fatty acids ratios on infarct size and the limbic system after myocardial infarction. Can J Physiol Pharmacol 2011; 89:169-76. [DOI: 10.1139/y11-007] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Changes in dietary omega-6/3 polyunsaturated fatty acids (PUFA) ratios affect anti- and proinflammatory equilibrium. As reperfused myocardial infarction (MI) is an inflammatory pathology that alters the cell integrity of the myocardium but also of other tissues, such as the hippocampus and amygdala, attenuation of the inflammation could be helpful in maintaining cell integrity after MI. Therefore, we hypothesized that a decrease in the dietary omega-6/3 PUFA ratio, without altering the diet content in total fat, proteins, or carbohydrates, will result in a reduction of infarct size and a diminution of postreperfusion apoptosis observed in the amygdala and hippocampus. Male Sprague–Dawley rats were fed 1 of 3 diets containing different omega-6/3 PUFA ratios for 2 weeks (5:1; 1:1; 1:5). Then, myocardial ischemia was induced by left anterior descending coronary artery occlusion for 40 min, followed by reperfusion. Cardioprotective mechanisms were studied in the myocardium at 15 min of reperfusion, along with myocardial infarct size after 24 h of reperfusion. Apoptosis was evaluated in the hippocampus and the amygdala. We found that infarct size was significantly reduced by 32% in groups 1:5 and 1:1 vs. group 5:1. Akt activity was higher in groups 1:5 and 1:1 compared with group 5:1. Caspase-3 enzymatic activity doubled in area CA1 and the dentate gyrus (DG) in group 5:1 compared with groups 1:1 and 1:5. In addition, caspase-8 enzymatic activity was increased in the DG at 24 h, and caspase-9 was enhanced in CA1 at 24 h in group 5:1 vs. groups 1:1 and 1:5. These results demonstrate that the increase in the dietary omega-3 PUFA, at the expense of omega-6 PUFA, reduces infarct size and helps to inhibit apoptosis in the limbic system after MI.
Collapse
Affiliation(s)
- I. Rondeau
- Centre de biomédecine, Hôpital du Sacré-Cœur de Montréal, 5400 Boul. Gouin Ouest, Montreal, QC H4J 1C5, Canada
- Département de pharmacologie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
- Département de psychiatrie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
| | - S. Picard
- Centre de biomédecine, Hôpital du Sacré-Cœur de Montréal, 5400 Boul. Gouin Ouest, Montreal, QC H4J 1C5, Canada
- Département de pharmacologie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
- Département de psychiatrie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
| | - T. M. Bah
- Centre de biomédecine, Hôpital du Sacré-Cœur de Montréal, 5400 Boul. Gouin Ouest, Montreal, QC H4J 1C5, Canada
- Département de pharmacologie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
- Département de psychiatrie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
| | - L. Roy
- Centre de biomédecine, Hôpital du Sacré-Cœur de Montréal, 5400 Boul. Gouin Ouest, Montreal, QC H4J 1C5, Canada
- Département de pharmacologie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
- Département de psychiatrie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
| | - R. Godbout
- Centre de biomédecine, Hôpital du Sacré-Cœur de Montréal, 5400 Boul. Gouin Ouest, Montreal, QC H4J 1C5, Canada
- Département de pharmacologie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
- Département de psychiatrie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
| | - G. Rousseau
- Centre de biomédecine, Hôpital du Sacré-Cœur de Montréal, 5400 Boul. Gouin Ouest, Montreal, QC H4J 1C5, Canada
- Département de pharmacologie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
- Département de psychiatrie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montreal, QC H3C 3J7, Canada
| |
Collapse
|
25
|
Murashkin NN, Ivanov AM, Zaslavsky DV, Kamilova TA. Studies on effectiveness and safety of system retinoids use in therapy ofadolescent acne. VESTNIK DERMATOLOGII I VENEROLOGII 2010. [DOI: 10.25208/vdv983] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
Abstract
The article describes up-to-date data on mechanics of epigenetic effects of system retinoid - isotretinoin (Roaccutane). It is
noted, that modern acne therapy is able not only to pathogenetically influence consequences of the process, but effect genetical
causes of desease, leading to persistant changes and normalization of regulatory segments DNA structure under influence of
isotretinoin. Also this article lists data on the use of isotretinoin (Roaccutane) for acne treatment of 237 adolescents. Studies were
performed on frequency of occurrence, degree of manifestation of secondary effects and methods of levereging this effects in
practical use. Authors state that correctly prescribed treatments are safe and do not cause serious secondary effects with in case
of long treatmetns.
Collapse
|
26
|
Jin XJ, Kim EJ, Oh IK, Kim YK, Park CH, Chung JH. Prevention of UV-induced skin damages by 11,14,17-eicosatrienoic acid in hairless mice in vivo. J Korean Med Sci 2010; 25:930-7. [PMID: 20514317 PMCID: PMC2877234 DOI: 10.3346/jkms.2010.25.6.930] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/09/2009] [Accepted: 09/24/2009] [Indexed: 11/29/2022] Open
Abstract
Polyunsaturated fatty acids (PUFAs) are known to play important roles in various physiological and pathological processes. Recent studies have shown that some omega-3 (omega-3) PUFAs, such as eicosapentaenoic acid (EPA) and dodecahexaenoic acid (DHA), have protective effects on acute and chronic UV-induced changes. However, the effects of other omega-3 PUFAs including 11,14,17-eicosatrienoic acid (20:3) (ETA) on UV-induced skin damages are poorly understood. In this study, we investigated the cutaneous photoprotective effects of ETA in hairless mice in vivo. Female HR-1 hairless mice were topically treated with vehicle (ethanol:polyethylene glycol=30:70) only, 0.1% ETA, or 1% ETA once a day for 3 successive days after one time UV irradiation (200 mJ/cm(2)) on dorsal skins. Skin biopsy was carried out on the fourth day (72 hr after UV irradiation). We found that topical treatment with ETA attenuated UV-induced epidermal and dermal thickness and infiltration of inflammatory cells, and impairment of skin barrier function. In addition, ETA suppressed the expression of IL-1beta, COX-2, and MMP-13 induced by UV irradiation. Our results show that the topical application of ETA protects against UV-induced skin damage in hairless mice and suggest that ETA can be a potential agent for preventing and/or treating UV-induced inflammation and photoaging.
Collapse
Affiliation(s)
- Xing-Ji Jin
- Department of Dermatology, Seoul Nationa University College of Medicine, Seoul, Korea
- Institute of Dermatological Science, Medical Research Center, Seoul National University, Seoul, Korea
- Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea
| | - Eun Ju Kim
- Department of Dermatology, Seoul Nationa University College of Medicine, Seoul, Korea
- Institute of Dermatological Science, Medical Research Center, Seoul National University, Seoul, Korea
- Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea
| | - In Kyung Oh
- Department of Dermatology, Seoul Nationa University College of Medicine, Seoul, Korea
- Institute of Dermatological Science, Medical Research Center, Seoul National University, Seoul, Korea
- Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea
| | - Yeon Kyung Kim
- Department of Dermatology, Seoul Nationa University College of Medicine, Seoul, Korea
- Institute of Dermatological Science, Medical Research Center, Seoul National University, Seoul, Korea
- Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea
| | - Chi-Hyun Park
- Department of Dermatology, Seoul Nationa University College of Medicine, Seoul, Korea
- Institute of Dermatological Science, Medical Research Center, Seoul National University, Seoul, Korea
- Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea
| | - Jin Ho Chung
- Department of Dermatology, Seoul Nationa University College of Medicine, Seoul, Korea
- Institute of Dermatological Science, Medical Research Center, Seoul National University, Seoul, Korea
- Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea
| |
Collapse
|
27
|
Castillero E, Martín AI, López-Menduiña M, Villanúa MA, López-Calderón A. Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors. Am J Physiol Regul Integr Comp Physiol 2009; 297:R1322-31. [PMID: 19741054 DOI: 10.1152/ajpregu.00388.2009] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid that has anti-inflammatory and anticachectic actions. The aim of this work was to elucidate whether EPA administration is able to prevent an arthritis-induced decrease in body weight and muscle wasting in rats. Arthritis was induced by intradermal injection of Freund's adjuvant; 3 days later, nine rats received 1 g/kg EPA or coconut oil daily. All rats were killed 15 days after adjuvant injection. EPA administration decreased the external signs of arthritis and paw volume as well as liver TNF-alpha mRNA. EPA did not modify arthritis-induced decrease in food intake or body weight gain. However, EPA treatment prevented arthritis-induced increase in muscle TNF-alpha and atrogin-1, whereas it attenuated the decrease in gastrocnemius weight and the increase in MuRF1 mRNA. Arthritis not only decreased myogenic regulatory factors but also increased PCNA, MyoD, and myogenin mRNA in the gastrocnemius. Western blot analysis showed that changes in protein content followed the pattern seen with mRNA. In the control rats, EPA administration increased PCNA and MyoD mRNA and protein. In arthritic rats, EPA did not modify the stimulatory effect of arthritis on these myogenic regulatory factors. The results suggest that in experimental arthritis, in addition to its anti-inflammatory effect, EPA treatment attenuates muscle wasting by decreasing atrogin-1 and MuRF1 gene expression and increasing the transcription factors that regulate myogenesis.
Collapse
Affiliation(s)
- Estíbaliz Castillero
- Department of Physiology, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain
| | | | | | | | | |
Collapse
|
28
|
Thuong PT, Kang KW, Kim JK, Seo DB, Lee SJ, Kim SH, Oh WK. Lithospermic acid derivatives from Lithospermum erythrorhizon increased expression of serine palmitoyltransferase in human HaCaT cells. Bioorg Med Chem Lett 2009; 19:1815-7. [DOI: 10.1016/j.bmcl.2009.01.052] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2008] [Revised: 12/15/2008] [Accepted: 01/09/2009] [Indexed: 12/11/2022]
|
29
|
Pan MH, Ho CT. Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 2008; 37:2558-74. [DOI: 10.1039/b801558a] [Citation(s) in RCA: 239] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|